1316 (1316) Fair Value & Analysis

Consumer Cyclical · Market cap HK$9.8B

1 1316 1316 · HK

PriceHK$3.81

Fair ValueHK$0.8900

Upside-76.6%

Quality49/100

Evidence: High Range HK$0.6700 – HK$1.12

Fair value as of: Jul 2, 2026

From 26 valuation models · updated today

Share price −19.5% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$3.81 – HK$8.39 · fair‑value band HK$0.6700 – HK$1.12 · the HK$3.81 price screens above the HK$0.8900 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1316 (1316) currently trades at HK$3.81, while our model-based Fair Value estimate is HK$0.8900 — implying the stock looks roughly 76.6% overvalued today. We read business quality at 49/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 1316 generated revenue of HK$4.6B at a net margin of 2.2%. Revenue grew 7.6% year over year. It earns a return on equity of 5.4%. The balance sheet holds a net cash position of HK$414M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$4.6B

Revenue growth (YoY) +7.6%

Net margin 2.2%

Return on equity 5.4%

Free cash flow HK$267M FY2025

P/E ratio 12.3

More key figures

Operating margin 4.3%

EPS (TTM) HK$0.0300

Dividend yield 0.5%

EPS growth (YoY) -16.3%

Net cash HK$414M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1316 reported revenue of HK$4.6B in FY2025 versus HK$3.4B in FY2021, a compound +8.1%/yr. Reported net income was HK$102M in FY2025, compounding −3.7%/yr from FY2021.

Revenue +8.1%/yr

FY21 HK$3.4B

FY22 HK$3.8B

FY23 HK$4.2B

FY24 HK$4.3B

FY25 HK$4.6B

Net income −3.7%/yr

FY21 HK$118M

FY22 HK$58.0M

FY23 HK$36.7M

FY24 HK$61.7M

FY25 HK$102M

Is 1316 fairly valued? → Check now

Similar stocks

6 more Auto Parts stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
O'Reilly Automotive, Inc ORLY34	R$1.49	R$0.4900	-67%
AutoZone, Inc AZOI34	R$73.14	R$10.17	-86%
Hyundai Mobis Co 012330	570,000 KRW	591,992 KRW	+4%
Fuyao Glass Industry Group 600660	¥50.05	¥111.37	+123%
Magna International Inc MGAN	1,182 MXN	1,064 MXN	-10%
Ningbo Tuopu Group 601689	¥63.21	¥19.12	-70%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1316 (1316) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.8900 versus a price of HK$3.81 — about −77% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1316?

Our model-based fair value for 1316 is HK$0.8900 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$3.81.

What is the quality score of 1316?

1316 has a Quality Score of 49/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1316 (1316)?

1316 reported trailing-twelve-month revenue of about HK$4.6B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1316?

The net profit margin of 1316 is about 2.2%, meaning it keeps roughly 2.2% of revenue as net income. Based on the latest reported figures.

Does 1316 pay a dividend?

1316 currently shows a dividend yield of about 0.47% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.